Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome
NCT03578497
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Polycystic Ovary Syndrome
Interventions
DRUG:
IL-1 receptor antagonist Anakinra
Sponsor
University Hospital, Basel, Switzerland